2116 related articles for article (PubMed ID: 26447017)
1. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
Woods AD; Giometti R; Weeks SM
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of interventions to meet family needs of critically ill patients in an adult intensive care unit: a systematic review update.
Kynoch K; Chang A; Coyer F; McArdle A
JBI Database System Rev Implement Rep; 2016 Mar; 14(3):181-234. PubMed ID: 27532144
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of preoperative intranasal dexmedetomidine, compared with oral midazolam, for the prevention of emergence delirium in the pediatric patient undergoing general anesthesia: a systematic review.
FitzSimons J; Bonanno LS; Pierce S; Badeaux J
JBI Database System Rev Implement Rep; 2017 Jul; 15(7):1934-1951. PubMed ID: 28708753
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol.
Fiore M; Torretta G; Passavanti MB; Sansone P; Pace MC; Alfieri A; Aurilio C; Simeon V; Chiodini P; Pota V
JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2159-2164. PubMed ID: 31232889
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis.
Nguyen J; Nacpil N
JBI Database System Rev Implement Rep; 2018 May; 16(5):1220-1239. PubMed ID: 29762314
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and harms of pharmacological interventions for the treatment of delirium in adults in intensive care units after cardiac surgery: a systematic review.
Leigh V; Stern C; Elliott R; Tufanaru C
JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2020-2074. PubMed ID: 31449136
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Severe Alcohol Withdrawal.
Schmidt KJ; Doshi MR; Holzhausen JM; Natavio A; Cadiz M; Winegardner JE
Ann Pharmacother; 2016 May; 50(5):389-401. PubMed ID: 26861990
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines for delirium.
Lonergan E; Luxenberg J; Areosa Sastre A; Wyller TB
Cochrane Database Syst Rev; 2009 Jan; (1):CD006379. PubMed ID: 19160280
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium.
Tolonen J; Rossinen J; Alho H; Harjola VP
Eur J Emerg Med; 2013 Dec; 20(6):425-7. PubMed ID: 23247391
[TBL] [Abstract][Full Text] [Related]
10. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.
Brotherton AL; Hamilton EP; Kloss HG; Hammond DA
Pharmacotherapy; 2016 Apr; 36(4):433-42. PubMed ID: 26893017
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials.
Fraser GL; Devlin JW; Worby CP; Alhazzani W; Barr J; Dasta JF; Kress JP; Davidson JE; Spencer FA
Crit Care Med; 2013 Sep; 41(9 Suppl 1):S30-8. PubMed ID: 23989093
[TBL] [Abstract][Full Text] [Related]
12. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
Collier TE; Farrell LB; Killian AD; Kataria VK
J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepines for alcohol withdrawal.
Ntais C; Pakos E; Kyzas P; Ioannidis JP
Cochrane Database Syst Rev; 2005 Jul; (3):CD005063. PubMed ID: 16034964
[TBL] [Abstract][Full Text] [Related]
14. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
Ferenchak TA
J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
[TBL] [Abstract][Full Text] [Related]
15. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
[TBL] [Abstract][Full Text] [Related]
17. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?
Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC
Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of patient navigation programs for adult cancer patients undergoing treatment: a systematic review.
Tho PC; Ang E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):295-321. PubMed ID: 27536800
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine for Alcohol Withdrawal Syndrome.
Linn DD; Loeser KC
Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
[TBL] [Abstract][Full Text] [Related]
20. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
